Work

Supplementary Figure 6 from SPHK1 Is a Novel Target of Metformin in Ovarian Cancer

Year: 2023

Type: supplementary-materials

Abstract: Silencing SPHK1 promotes resistance to metformin-induced cytotoxicity.

DOI: 10.1158/1541-7786.22512996

Authors: Peter C. Hart, Tatsuyuki Chiyoda, Xiaojing Liu, Melanie Weigert, Marion Curtis, Chun-Yi Chiang, Rachel Loth, Ricardo Lastra, Stephanie M. McGregor, Jason W. Locasale, Ernst Lengyel, Iris L. Romero

Language: English

Topic: Metabolism, Diabetes, and Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362483080

Cites:

Cited by:

Related to: 10